Table 1 Comparison patient parameters among survivors and nonsurvivors

Age, mean

63.07 ± 20.7

59.11 ± 21.9

70.79 ± 16.1

0.045*

Sex, males (%)

41 (73.2%)

27 (73%)

14 (73.7%)

0.955

APACHE II score

19.38 ± 7.7

17.32 ± 7.6

23.37 ± 6.2

0.004*

Predicted death rate (%)

36.87 ± 22.6

31.05 ± 21.7

48.19 ± 20.2

0.006*

Nonalbicans infection

44 (78.6%)

31 (83.8%)

13 (68.4%)

0.302

Co-existing candiduria

15 (26.8%)

10 (27%)

5 (26.3%)

0.955

Underlying co-morbidities

41 (73.2%)

24 (64.9%)

18 (94.7%)

0.021*

Previous antimicrobials

49 (87.5%)

33 (89.2%)

16 (84.2%)

0.679

Previous antifungals

8 (14.3%)

1 (0.3%)

7 (36.8%)

0.001*

Days in ICU before positive culture

12.88 ± 14.4

13.05 ± 14.6

12.53 ± 14.3

0.898

Recent hospitalization

17 (30.4%)

11 (29.7%)

6 (31.6%)

0.887

Total parenteral nutrition

18 (32.1%)

15 (40.5%)

3 (15.8%)

0.076

Candida score (≥3)

29 (51.8%)

15 (40.5%)

14 (73.7%)

0.025*

Presence of CVC

49 (87.5%)

31 (83.8%)

18 (94.7%)

0.403

Mechanical ventilation

36 (64.3%)

19 (51.4%)

17 (89.5%)

0.007*

Vasopressor support

30 (53.6%)

13 (35.1%)

17 (89.5%)

0.000*

Renal replacement therapy

23 (41.1%)

9 (24.3%)

14 (73.7%)

0.001*

Length of ICU stay (days)

22.86 ± 28

22.35 ± 31.4

23.84 ± 20.6

0.853

Length of hospital stay (days)

30.09 ± 30.2

33.19 ± 33.8

24.05 ± 21.1

0.288